Navigation Links
RxElite Registration Statement Declared Effective by Securities and Exchange Commission
Date:1/3/2008

MERIDIAN, Idaho, Jan. 3 /PRNewswire-FirstCall/ -- RxElite, Inc. (OTC Bulletin Board: RXEI), a developer, manufacturer, and marketer of specialty generic prescription drug products, announced today that a registration statement covering the resale of 53,747,555 shares by selling stockholders was declared effective by the Securities and Exchange Commission on January 2, 2008.

This notice is provided for informational purposes only, and does not represent a solicitation or offer to buy or sell any security. Any offer will be made my means of a current prospectus only. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sales of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing,
'/>"/>

SOURCE RxElite, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. RxElite Announces 3rd Quarter Financials Conference Call
2. RxElite Files Registration Statement with Securities and Exchange Commission
3. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
4. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
5. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
6. FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A.
7. Pearson Introduces Smart Technology for Collecting Patient Registration Information
8. Uroplasty, Inc. Announces Filing of Registration Statement for Offering of Common Stock
9. PA Governors Occupational Safety and Health Conference Still Accepting Registrations
10. Gentiva(R) Health Services Files Universal Shelf Registration Statement
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...rom replicating in the livers of primates , , ...w drug to treat hepatitis C has shown promise in a...s a new strategy to prevent the hepatitis C virus ...get the virus itself, the new DNA-based drug targe...s C needs to replicate, the researchers explained....
(Date:12/3/2009)...ec. 3 An exciting treatment gainin...alled platelet-rich plasma therapy (PRP), is showi...tal implant procedures, according to a prominent d...l Implantology . ,, James Rutkowski, DMD, PhD... of the American Academy of Implant Dentistry that...
(Date:12/3/2009)...Deutsches rzteblatt International contains the fi...e with the novel influenza A virus (H1N1/09) in th... pandemic. Ralf Winzer and his coauthors from the ...uated data from a large clinical cohort of infecte...6[47]: 770-6). Their medical-scientific article is...
(Date:12/3/2009)... 450 Deaths a day is still too many - stalled m... Atlanta, GA, Geneva, New Yor...-- The Measles Initiative announced today that mea... 2008, from an estimated 733 000 in 2000 to 164 00...rn of a resurgence in measles deaths if vaccinatio...
(Date:12/3/2009)... Nutra Pharma will be conducting a webinar on D...ver-the-counter and prescription treatments for ch... Plantation, FL (Vocus) December 3, 2...nology company that is developing treatments for A...osis (MS), has announced today that it will be hos...
Breaking Medicine News(10 mins):Health News:New Hepatitis C Treatment Shows Promise 2Health News:New Hepatitis C Treatment Shows Promise 3Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 2Health News:Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain 3
...rchers from Sweden say they have found that implan...d with coronary vasoconstriction in areas adjacent...metal stents. Sirolimus-eluting stents are w...ve been raised that the stents could lead to incre...
...he Patna Medical College and Hospital (PMCH) //jun...This order came after hearing a filed petition, th...e its start on Friday. The death of several cr...icially that the ongoing strike has caused at leas...
...andwashing with soap prevents the two clinical s...espiratory infections. These two infections ha...f children under 5 years of age every year in th...in Karachi, Pakistan, neighbourhoods were randoml...
...rs in persons who have an unnecessary increased we...that eating disorders occurs mostly in men. Eating...or this disorder are mostly due to people with inc... shape – ‘body image disturbance’. Person with sym...
...cer killers in industrial countries and affects //...umber is expected to increase with the ageing popu...Researchers now say that a daily supplement contai... men. Researchers from the Erasmus Medical C...
...mainly farm animals and spread in humans// by inha...n prove fatal if immediate action is not taken. No...e state of Tamil Nadu has renewed anxiety about t... the border of Kerala and Tamil Nadu that is known...
Other Medicine News:Health News:Analyzing The Side Effects Of Sirolimus Stents 2Health News:Eating disorder occurs due to increased weight consciousness 2Health News:Tackling Prostate Cancer With A New Dietary Supplement 2Health News:Anthrax Scare In Tamil Nadu State of India 2
(Date:12/3/2009)..., ROTTERDAM, The Netherlands, December 3 /PR...ny focused on the discovery and development of hum...y(TM) platform, today,announced the successful sec.... The Company raised an additional EUR 3.0 million...investors, Credit Agricole Private Equity and,VIB ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Hospital Informa...mp; Opportunities ,, http://www.reportlinker....al-Update-of-Market-Trends--Opportunities.html ,...rons on the benefits of using Information Technolo...
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com...ailable in its catalogue: ,, EEG/EMG/Brain Fu...http://www.reportlinker.com/p0164319/EEG/EMG/Brain...,, Steep rise in obesity, cardiovascular, and a...cephalograph (EEG) diagnostic and monitoring equip...
Breaking Medicine Technology:arGEN-X Concludes EUR 12.5 Million Series A Financing Round 2arGEN-X Concludes EUR 12.5 Million Series A Financing Round 3arGEN-X Concludes EUR 12.5 Million Series A Financing Round 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 8Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 2Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 3Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 4Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 5Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 6Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 7Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 8Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 1Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 2Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 3Book by UCR biologist tells story of 100 year quest for elusive malaria vaccine 58462 4Nanotechnology and synthetic biology 3A What does the American public think 3F 10157 1Nanotechnology and synthetic biology 3A What does the American public think 3F 10157 2New blood thinning drug safer than rat poison 10154 1
... 2007 /PRNewswire/ - Cytochroma Inc.,announced tod...CTA018 Injection. The initial top-line results fro...tolerated. Complete study,results are expected in ...l was an open label,placebo-controlled, randomize...lthy volunteers. In this trial, the safety of,CTA0...
...INESS WIRE)--Jun 28, 2007 - CombinatoRx,Incorpora...ults of,its randomized, blinded, placebo-controlle...atoid arthritis (RA). The trial,compared CRx-150 p...) to placebo plus DMARD (control) in subjects with...ial, CRx-150 demonstrated,statistically significan...
Other Medicine Technology:Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 2Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 3CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 2CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 3CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 4CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and,Pain, but Not CRP 5
Reusable Thoracoscopy Cannula
...eatured trocar that consists of a flat bladed tip ...signed to cover the flat bladed tip to protect int...the abdominal or thoracic cavity has been entered.... to enhance trocar sleeve fixation in the patient....
...onsists of a sharp pyramidal blade, and spring-loa...ramidal tip to protect internal structures from pu...c cavity has been entered. Due to reduced force to...red. , ,The single-patient use trocar sleeve hous...
MultAcoice™ Metzenbaum Straight Scissors
Medicine Products: